“Prozac is what I call the Big Bang of pharmaceutical naming. It came out of nowhere, it means absolutely nothing, and it really just said, ‘Wow, OK, this is blockbuster naming in the drug world’,” Scott Piergrossi, vice president of creative development at the Brand Institute, tells CNN.
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.